pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,900 catalysts · 5,256 phase readout · 2,298 8k filing · 343 pdufa · 255 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,298
  • pdufa343
  • earnings255
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07329777: Atropine in the Treatment of Myopia Study in Malaysia

Sponsor: IDB VisionCare SDN BHD. Phase: PHASE3. Conditions: Myopia Progression

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07386977: Effects of Visual Feedback on Angular Error

Sponsor: Lokman Hekim University. Phase: . Conditions: Knee Osteoarthritis, Gonarthrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05410977: Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

Sponsor: Mayo Clinic. Phase: . Conditions: Colorectal Carcinoma, Lynch Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT04159675: Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Craniosynostoses

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06754501: A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07305779: A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.. Phase: PHASE1. Conditions: Schizophrenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07481396: Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics

Sponsor: Chungnam National University Hospital. Phase: . Conditions: Cardiac Arrest (CA), Cerebrospinal Fluid, Multiomics, Hypoxic-Ischemic Brain Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT06650488: Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Sponsor: Todd C. Lee MD MPH FIDSA. Phase: PHASE4. Conditions: Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bloodstream Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07501988: The Effect Of Color Rotation Technique Training On İnsülin Self-management İn Diabetic Patients.

Sponsor: Tokat Gaziosmanpasa University. Phase: NA. Conditions: Diabete Mellitus, İnsulin Self-management

full page →ctgov ↗
›COMPLETEDphase readoutNCT07487688: Five-Year CT Follow-Up of Vertebral Fracture Risk Using Opportunistic Osteoporosis Screening

Sponsor: Technical University of Munich. Phase: . Conditions: Osteoporosis, Fracture Risk Assessment, Osteoporotic Fracture of Vertebra

full page →ctgov ↗
›RECRUITINGphase readoutNCT06821503: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Advanced Pancreatic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03895203: A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

Sponsor: UCB Biopharma SRL. Phase: PHASE3. Conditions: Psoriatic Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07482527: Thoracic Mobility Versus Hip Mobility Exercises to Core Stabilization in Lumbar Spondylitis

Sponsor: Cairo University. Phase: NA. Conditions: Individuals With Lumbar Spondylosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06561386: A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Sponsor: Bristol-Myers Squibb. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07174986: Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest

Sponsor: Gabriel Riva. Phase: PHASE2. Conditions: Out of Hospital Cardiac Arrest, Ventricular Fibrillation, Defibrillation, CPR, ACLS, Sudden Death

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07500870: Comparative Evaluation of Endodontic Instrumentation Kinematics and Cryotherapy on Post-endodontic Pain and Periapical Healing

Sponsor: All India Institute of Medical Sciences. Phase: NA. Conditions: Post Endodontic Pain, Periapical Healing

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06247670: Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype

Sponsor: CAMP4 Therapeutics Corporation. Phase: PHASE1. Conditions: Healthy Volunteers, OTC Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT06016842: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Sponsor: Ipsen. Phase: PHASE3. Conditions: Primary Biliary Cholangitis (PBC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06792786: A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Sponsor: The Central Hospital of Lishui City. Phase: NA. Conditions: Esophageal Cancer, ctDNA

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07557186: Validity and Reliability of Kinovea Software Measurement of Lumbar Extensibility Using Modified-Modified Schober Test

Sponsor: Cairo University. Phase: . Conditions: Lumbar Extensibility

full page →ctgov ↗
›RECRUITINGphase readoutNCT06710769: Ovarian Tissue Cryopreservation

Sponsor: Phoenix Children's Hospital. Phase: NA. Conditions: Infertility, Female

full page →ctgov ↗
›RECRUITINGphase readoutNCT07420283: A Study of Brenipatide in Participants With Opioid Use Disorder

Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Opioid Use Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07576569: Nursing Intervention for Adaptation After Myocardial Revascularization

Sponsor: Universidad de la Sabana. Phase: NA. Conditions: Coronary Artery Disease, Myocardial Revascularization, Postoperative Recovery After Cardiac Surgery, Nursing Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT07347054: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA)

Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Myofascial Trigger Points, Chronic Musculoskeletal Pain, Shoulder Osteoarthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06514794: A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Sponsor: Wugen, Inc.. Phase: PHASE2. Conditions: T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05826366: Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Sponsor: AstraZeneca. Phase: . Conditions: Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗
›RECRUITINGphase readoutNCT03850366: HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Sponsor: Henry Ford Health System. Phase: PHASE2. Conditions: Hematological Malignancy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07516366: Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT07249684: Myofascial Release And Static Stretching Along With Nighttime Bracing

Sponsor: Riphah International University. Phase: NA. Conditions: Clubfoot Deformity

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06868784: Investigation of the Relationship Between Executive Functions and Occupational Performance of Children With Duchenne Muscular Dystrophy

Sponsor: Lokman Hekim University. Phase: . Conditions: Executive Dysfunction, Occupational Problems, Duchenne Muscular Dystrophy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07442084: Efficacy of Modified Si Ni San in Post-Polypectomy Management and Its Impact on Gut Microbiota in Colorectal Polyp Patients

Sponsor: Xi'an Hospital of Traditional Chinese Medicine. Phase: NA. Conditions: Colorectal Polyps, Modified SiNiSan

full page →ctgov ↗
›COMPLETEDphase readoutNCT03988933: 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre. Phase: PHASE2. Conditions: Latent Tuberculosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05253352: Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway

Sponsor: Beth Israel Deaconess Medical Center. Phase: . Conditions: Lymphatic System

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07220252: Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

Sponsor: TG Therapeutics, Inc.. Phase: PHASE2. Conditions: Relapsing Multiple Sclerosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05269238: Improvement of the Performance of Lumbar Punctures After Training Students With an Augmented Reality SIMulator

Sponsor: University Hospital, Strasbourg, France. Phase: NA. Conditions: Lumbar Puncture

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07440238: Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Septic Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07171138: This Study Will Use Real-time Pressure Mapping Technology to Determine Which Positioning Strategies and Devices Exert the Least Amount of Pressure on Peri-operative Burn Patients

Sponsor: Sunnybrook Health Sciences Centre. Phase: NA. Conditions: Hospital Acquired Pressure Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT06870058: A Study of NH280105 in Healthy Adult Participants

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Alzheimer Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT01212055: Apheresis of Patients With Immunodeficiency

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: LAD-1, DOCK8, GATA2 Deficancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06751355: Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

Sponsor: Washington University School of Medicine. Phase: . Conditions: Kaposi Sarcoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07359352: Surgical Care And Recovery With Laser Evaluation Trial (SCARLET)

Sponsor: AdventHealth. Phase: NA. Conditions: Post-surgical Scars, Hypertrophic Scars, Scar Appearance Dissatisfaction, Aesthetic Surgical Outcomes, Wound Healing After Body-contouring Surgery

full page →ctgov ↗
›COMPLETEDphase readoutNCT04859543: Pediatric Prospective Personalized Immune and Target Identification Trial

Sponsor: Masaryk University. Phase: NA. Conditions: Central Nervous System Neoplasms, Pediatric Cancer, GEN1 Gene Mutation, Tumor, Brain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06970743: A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

Sponsor: BeOne Medicines. Phase: PHASE3. Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05661643: The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Gastrointestinal Stromal Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06855043: Little Lungs Study

Sponsor: University of Wisconsin, Madison. Phase: PHASE1. Conditions: Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT05274243: 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis

Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Rheumatoid Arthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT00200343: Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Hepatitis C

full page →ctgov ↗
›RECRUITINGphase readoutNCT06722508: Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

Sponsor: University of California, Davis. Phase: NA. Conditions: Head Cancer, Neck Cancer, Sarcopenia, Head and Neck Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07484308: Application and Impact Assessment of Ultrasound Super-Resolution Blood Flow Imaging (URM) in Patients With Renal Failure

Sponsor: Ma Zhe. Phase: NA. Conditions: Kidney Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT06331325: Comparison of Frenotomy and Frenectomy Techniques for Management of High Frenum Attachment in Adults

Sponsor: October University for Modern Sciences and Arts. Phase: NA. Conditions: High Frenum Attachment

full page →ctgov ↗
← prev
page 81 of 158
next →